Royal Bank of Canada Issues Pessimistic Forecast for Apellis Pharmaceuticals (NASDAQ:APLS) Stock Price
Apellis Pharmaceuticals (NASDAQ:APLS – Get Free Report) had its price target cut by investment analysts at Royal Bank of Canada from $24.00 to $21.00 in a research note issued on Monday,Benzinga reports. The brokerage presently has a “sector perform” rating on the stock. Royal Bank of Canada’s price objective suggests a potential upside of 20.90% […]
More Stories
Trump Warns ‘Biggest Threat’ to US Would Be Supreme Court Overruling Tariffs
By Jack Phillips President Donald Trump on Tuesday said that national security could be at risk if the Supreme Court...
Federal Reserve Poised to Cut Interest Rates at Final Meeting of 2025
By Andrew Moran The Federal Reserve’s final policy meeting of the year is expected to end with an interest rate...
Will Japanese Series, The Fragrant Flower Blooms With Dignity, Return for Season 2?
The Japanese animated drama, The Fragrant Flower Blooms With Dignity, is getting praised by many viewers from around the world....
6 Best Analytics Agencies in 2026 to Level Up Your Data Strategy
What do businesses do? Build and innovate from raw and scratch, right? But creation generates its own new raw material,...
Dalton Gomez Net Worth: How Rich Is Ariana Grande’s Ex-Husband?
He became popular following his affair with Ariana Grande. Even before he got into a relationship with Ariana, he was...
Trump Admin Aims to Create Family-Friendly Airports With Healthier Foods, Exercise Areas
By Jill McLaughlin The Trump administration is ready to spend $1 billion to create healthier food options, private breastfeeding pods,...